Print

ImmunoCellular Therapeutics, Ltd to Present at ROTH Conference on March 18th  
3/12/2013 6:21:00 AM

ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced that Andrew Gengos, Chief Executive Officer of ImmunoCellular, will present a corporate overview and business update at the 25th Annual ROTH Conference on Monday, March 18, 2013 at 1:30 pm PT at the Ritz-Carlton, Laguna Niguel, CA.
//-->